ONRIVA PLUS 110mcg+50mcg BEXICAP contains Indacaterol 110 mcg + Glycopyrronium 50 mcg. It is a long-acting bronchodilator combination medicine used to relax airway muscles and improve breathing in patients with chronic obstructive pulmonary disease (COPD).
Uses:
Long-term maintenance treatment of COPD.
Relief of breathing difficulties such as shortness of breath, wheezing, and chest tightness.
Helps open the airways and improve airflow.
Reduces COPD symptoms and improves exercise tolerance.
Helps prevent worsening of COPD symptoms.
Dose:
Adults: Usually one inhalation once daily, or as directed by a physician.
Use with the BEXICAP inhaler device as instructed by a healthcare professional.
Do not swallow the capsule; it is meant for inhalation only.
Dose and duration depend on the patient's condition and response to treatment.